CoChat

Estrogens and Glucocorticoids in Mammary Adipose Tissue: Relationships with Body Mass Index and Breast Cancer Features

Open access
Laforest, Sofia, Pelletier, Mélissa, Denver, Nina, Poirier, Brigitte, Nguyen, Sébastien, Walker, Brian R, Durocher, Francine, Homer, Natalie Z M, Diorio, Caroline, Andrew, Ruth, Tchernof, André · 2020 · The Journal of Clinical Endocrinology & Metabolism

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Abstract

Context: Adipose tissue is an important site for extragonadal steroid hormone biosynthesis through the expression and activity of P450 aromatase, 11β-hydroxysteroid dehydrogenase (HSD) 1, and 17β-HSDs. The contribution of steroid hormones produced by adjacent adipose tissue for the progression and survival of breast tumors is unknown. Objective: To quantify estrogens (estradiol, estrone) and glucocorticoids (cortisol, cortisone) in breast adipose tissue from both healthy and diseased women and their relationships with adiposity indices and breast cancer prognostic markers. Design and setting: Breast adipose tissue was collected at time of surgery. Patients: Pre- and postmenopausal women undergoing partial mastectomy for treatment of breast cancer (n = 17) or reduction mammoplasty (n = 6) were studied. Interventions: Relative estrogen and glucocorticoid amounts were determined by liquid chromatography tandem mass spectrometry. Results: The targeted steroids were reliably detected and quantified in mammary adipose tissues. Women with ER+/PR+ tumor had higher relative estradiol amount than women with ER–/PR– tumor (P < .05). The ratio of estradiol-to-estrone was higher in lean women than in women with a body mass index (BMI) ≥ 25 kg/m2 (P < .05). Mixed-model analyses showed that estradiol, cortisone, and cortisol were negatively associated with tumor size (P < .05). Relationships between glucocorticoids and tumor size remained significant after adjustment for BMI. The cortisol-to-cortisone ratio was negatively associated with tumor stage (P < .05) independently of BMI. Conclusions: We reliably quantified estrogens and glucocorticoids in breast adipose tissue from healthy women and women suffering from breast cancer. Our findings suggest that smaller breast tumors are associated with higher relative amounts of estradiol and cortisol in adipose tissue.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/clinem/dgz268

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Size distribution of breast adipocytes. (A) Comparison between control and case women (t-test, P = .0072; KS, P = .0041; n = 22). (B) Comparison between premenopausal and postmenopausal women (t-test, P = .0510; KS, P = .0864; n = 22). (C) Comparison between premenopausal and postmenopausal women with cancer (t-test, P = .0552; KS, P = .0480; n = 16).
Figure 1. Size distribution of breast adipocytes. (A) Comparison between control and case women (t-test, P = .0072; KS, P = .0041; n = 22). (B) Comparison between premenopausal and postmenopausal women (t-test, P = .0510; KS, P = .0864; n = 22). (C) Comparison between premenopausal and postmenopausal women with cancer (t-test, P = .0552; KS, P = .0480; n = 16).CC BY · PubMed Central
Figure 2. Adiposity and estrogens in breast adipose tissue. (A) Difference of the estradiol:estrone ratio according to body mass index (BMI) status using 25 kg/m2 as a cut-off (P = .0335, n = 23). (B) Difference of relative estradiol amounts in women with cancer according to BMI status using 25 kg/m2 as a cut-off (P = .0494, n = 17). Data on graphs are mean. Open circles represent premenopausal women data points and filled circles represent postmenopausal women data points. *P < .05.
Figure 2. Adiposity and estrogens in breast adipose tissue. (A) Difference of the estradiol:estrone ratio according to body mass index (BMI) status using 25 kg/m2 as a cut-off (P = .0335, n = 23). (B) Difference of relative estradiol amounts in women with cancer according to BMI status using 25 kg/m2 as a cut-off (P = .0494, n = 17). Data on graphs are mean. Open circles represent premenopausal women data points and filled circles represent postmenopausal women data points. *P < .05.CC BY · PubMed Central
Figure 3. Breast cancer clinical features and relative breast adipose tissue steroid amounts. (A) Mixed-model regression between relative estradiol amount (log-transformed) and tertiles of tumor size adjusted for menopausal status and current intake of hormonal derivatives (β 2 = –0.9785, β 3 = –1.1197; P = .0488). (B) Mixed-model regression between relative cortisol amount (log-transformed) and tumor size (continuous) adjusted for body mass index (BMI), menopausal status, and current intake of hormonal derivatives (β = –0.02135, P = .0027). (C) Mixed-model regression between relative cortisone amount (log-transformed) and tumor size (continuous) adjusted for BMI, menopausal status, and current intake of hormonal derivatives (β = –0.03636, P < .0001). (D) Mixed-model between cortisol:cortisone ratio (log-transformed) and tumor stage adjusted for BMI (β 2 = –1.8720, β 3 = –1.8316; P = .0410). (E) Difference in relative estradiol and estrone amounts in ER–/PR– vs ER+/PR+ women (P = .0134 and P = .0454). Data on graphs are mean. n = 17. Open circles represent premenopausal women data points and filled circles represent postmenopausal women data points. *P < .05.
Figure 3. Breast cancer clinical features and relative breast adipose tissue steroid amounts. (A) Mixed-model regression between relative estradiol amount (log-transformed) and tertiles of tumor size adjusted for menopausal status and current intake of hormonal derivatives (β 2 = –0.9785, β 3 = –1.1197; P = .0488). (B) Mixed-model regression between relative cortisol amount (log-transformed) and tumor size (continuous) adjusted for body mass index (BMI), menopausal status, and current intake of hormonal derivatives (β = –0.02135, P = .0027). (C) Mixed-model regression between relative cortisone amount (log-transformed) and tumor size (continuous) adjusted for BMI, menopausal status, and current intake of hormonal derivatives (β = –0.03636, P < .0001). (D) Mixed-model between cortisol:cortisone ratio (log-transformed) and tumor stage adjusted for BMI (β 2 = –1.8720, β 3 = –1.8316; P = .0410). (E) Difference in relative estradiol and estrone amounts in ER–/PR– vs ER+/PR+ women (P = .0134 and P = .0454). Data on graphs are mean. n = 17. Open circles represent premenopausal women data points and filled circles represent postmenopausal women data points. *P < .05.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 62 references

Cited by

See all 25

Metadata

Authors
Laforest, S., Pelletier, M., Denver, N., Poirier, B., Nguyen, S., Walker, B. R., Durocher, F., Homer, N. Z. M., Diorio, C., Andrew, R., & Tchernof, A.
Affiliations
  • Institut universitaire de cardiologie et de pneumologie de Québec (CA)
  • The Queen's Medical Research Institute (GB)
  • Hôpital du Saint-Sacrement (CA)
  • Université Laval (CA)
Corresponding author
Tchernof, André
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2019-12-20
Volume
105
Issue
4
Pages
e1504-e1516
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2995021728
Cited by
23
References
62
Citations by year
2026: 4 · 2025: 3 · 2024: 4 · 2023: 4 · 2022: 2 · 2021: 1 · 2020: 4
FWCI
1.05
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
  • Strathprints: The University of Strathclyde institutional repository (University of Strathclyde) (submittedVersion)
  • Corpus Université Laval (Université Laval) (submittedVersion)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
  • Cardiometabolic Health, Diabetes and Obesity Research Network
  • FRQS
  • Canadian Institutes of Health Research
  • Institute of Nutrition and Functional Foods
  • FRQNT
  • Wellcome Trust
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
  • Health Sciences › Medicine › Oncology › Cancer Risks and Factors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Keywords
breast adipose tissue, estrogen, glucocorticoids, estradiol, estrone, cortisol, cortisone, body mass index, breast cancer, aromatase, 11β-hydroxysteroid dehydrogenase type 1, 17β-hydroxysteroid dehydrogenase, tumor size, tumor stage, hormone receptor status, adiposity
MeSH terms
Adipose Tissue, Breast Neoplasms, Estrogens, Female, Follow-Up Studies, Glucocorticoids, Humans, Mastectomy, Menopause, Middle Aged, Prognosis, Body Mass Index

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Estrogens and Glucocorticoids in Mammary Adipose Tissue: Relationships with Body Mass Index and Breast Cancer Features. https://app.cochat.ai/papers/10.1210/clinem/dgz268
The paper
Laforest, S., Pelletier, M., Denver, N., Poirier, B., Nguyen, S., Walker, B. R., Durocher, F., Homer, N. Z. M., Diorio, C., Andrew, R., & Tchernof, A. (2020). Estrogens and Glucocorticoids in Mammary Adipose Tissue: Relationships with Body Mass Index and Breast Cancer Features. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgz268

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.